A World Health Organization (WHO) expert panel countered concerns over the efficacy of the AstraZeneca COVID vaccine on Wednesday, insisting that “it’s
To speed up access to COVID-19 vaccinations in the developing world, on the eve of the new year, the UN health agency approved Pfizer and BioNTech’s vaccines for emergency use.
More
Vaccines that protect against COVID-19 have been developed in record time over the year but, amid fears that people from poorer countries may miss out, the UN has consistently insisted on global solidarity, to ensure that all are protected. In the final part of our series on the ways that the virus has changed the
More
A COVID-19 vaccine developed by a Chinese drugmaker is the first to be granted official approval by China’s government.
More
Tough New Year’s Eve restrictions are being put in place as Australia’s biggest city struggles to contain growing coronavirus clusters.
More
In the final World Health Organization (WHO) COVID-19 press conference of the year, on Monday, senior officials warned that the virus is "not necessarily the big one", and that there is a real chance of another, more serious pandemic spreading across the world.
More
The head of Iran’s Red Crescent Society says the country will receive a shipment of coronavirus vaccines developed by Pfizer and BioNTech in three weeks.
More
Today, the European Commission adopted a package of €70 million under the Instrument for Pre-Accession (IPA II) to help fund the access of Western Balkans partners to COVID-19 vaccines procured by EU Member States.
More
In Italy, a large proportion of patients with coronavirus disease 2019 (COVID-19) presented with symptoms (71.4% of 31 845 confirmed cases as of June 3, 2020). Common symptoms include cough, fever, dyspnea, musculoskeletal symptoms (myalgia, joint pain, fatigue), gastrointestinal symptoms, and anosmia/dysgeusia.
More
COVID-19 and lockdown measures drove some individuals more than others to use alcohol to cope with stress, a new study has revealed. While overall alcohol consumption appeared to fall, a study published in BMJ Open found that more than one in three adults (36%) increased their consumption during the first lockdown.
More